Eli Lilly & Co. Inc.'s stock (LLY) rose 2.3% Wednesday, after the company said its Zepbound weight-loss drug was more effective than rival Novo Nordisk's Wegovy in a head-to-head study.
The nonprofit Children's Health Defense that Kennedy led has filed nearly 30 federal and state lawsuits since 2020, many ...
Thousands of eggs sold at Costco under the Kirkland Signature brand have been recalled due to potential salmonella ...
Research in idiopathic pulmonary fibrosis is progressing rapidly, with the goal of delivering more treatments to patients at ...
FDA, industry advocate for standard 'Best if Used By' date labels to reduce consumer confusion about food safety that could ...
The Alliance for Pharmacy Compounding rebutted Novo's FDA petition to bar compounding pharmacies from copying its weight loss ...
A safety alert by the FDA now covers 25 products sold as tejocote but found to contain a toxic plant called yellow oleander.
Are you confused by food label terms like “Sell By,” “Use By” and “Best By?” If so, you aren’t alone. Federal regulators ...
Amid the turmoil that has engulfed Oregon Health & Science University for the past two years comes a body blow to the city’s ...
Results from the head-to-head study showed treatment with Zepbound resulted in 47% greater relative weight loss than Wegovy, ...
It's unclear to what extent RFK Jr would want to disrupt a drug review process that has given the US a comparative advantage, ...
If we are going to be a nation that prioritizes public health, then we must work to make the FDA’s regulatory processes more effective.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback